J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:January 25, 2018 Post category:BioPharma Now insiders say J&J has decided it is no longer interested. Source: BioSpace You Might Also Like Siemens Healthineers And HeartFlow Collaborate To Provide Solution That Has Potential To Lower Cardiac Care Costs March 16, 2017 Why Pfizer's 2017 Was Mediocre at Best December 12, 2017 Capricor Second Quarter 2017 Update Webcast And Conference Call Scheduled For Thursday, August 10 August 3, 2017
Siemens Healthineers And HeartFlow Collaborate To Provide Solution That Has Potential To Lower Cardiac Care Costs March 16, 2017
Capricor Second Quarter 2017 Update Webcast And Conference Call Scheduled For Thursday, August 10 August 3, 2017
